
KLOW is a proprietary four-peptide research blend containing KPV, GHK-Cu, TB-500, and BPC-157, currently being studied for their complementary interactions across anti-inflammatory signaling, extracellular matrix regulation, and cellular biology research pathways in controlled laboratory settings. This compound is supplied exclusively for scientific research and is not approved for human or animal consumption.
● In Stock & Ready to Ship from USA
KLOW is a proprietary four-peptide research blend containing KPV, GHK-Cu, TB-500, and BPC-157, currently being studied for their complementary interactions across anti-inflammatory signaling, extracellular matrix regulation, and cellular biology research pathways in controlled laboratory settings. This compound is supplied exclusively for scientific research and is not approved for human or animal consumption.
Laboratory: Freedom Diagnostics (USA)
Principal Chemist: Stephen Schmidt
Methods: HPLC with UV Detection + LCMS/MS
Result: 99.889% purity verified
Every lot ships with a published COA documenting purity, identity, and verified peptide content.
Download COA (PDF)KLOW is a precision-formulated four-component research blend developed by 21 Peptide, containing KPV (Lys-Pro-Val, an α-MSH-derived tripeptide), GHK-Cu (copper tripeptide-1), TB-500 (Thymosin Beta-4, 43 amino acid chain), and BPC-157 (Body Protection Compound pentadecapeptide). Each component is individually studied in experimental biology, and together they represent a multi-mechanism research system targeting several complementary pathways across cellular signaling, extracellular matrix regulation, melanocortin receptor biology, and connective tissue research.
Current research investigates the individual components of KLOW across a range of biological systems, including skin fibroblast models, melanocortin receptor pathway studies, anti-inflammatory signaling research, connective tissue biology investigations, and cytoskeletal dynamics research. Studies conducted in controlled laboratory settings have examined KPV for its melanocortin receptor interactions, GHK-Cu for its collagen synthesis signaling, BPC-157 for its multi-tissue signaling activity, and Thymosin Beta-4 for its actin-binding properties.
21 Peptide™ supplies KLOW exclusively for scientific research purposes. This compound is not approved for human or animal consumption and is not intended for diagnostic, therapeutic, or clinical use.
Component 1:
KPV CAS NO: 67727-97-3
Molecular Formula: C₁₆H₃₀N₄O₄
Molecular Weight: 342.43 g/mol
Component 2:
GHK-Cu CAS NO: 49557-75-7
Molecular Formula: C₁₄H₂₄N₆O₄
Molecular Weight: 340.39 g/mol
Component 3:
TB-500 (Thymosin Beta-4) CAS NO: 77591-33-4
Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: 4963 g/mol
Component 4: BPC-157 CAS NO: 137525-51-0
Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1419.54 g/mol
Appearance: Blue lyophilized powder
Storage: 2-8°C
Quality Control
Lot Number: 21P-KLOW-2602-YEL
Purity: 99.889%
Verified Peptide Content: GHK-Cu: 65.30 mg / KPV: 14.84 mg / BPC-157: 15.31 mg / TB-500: 13.61 mg
Testing Method: HPLC with UV Detection + LCMS/MS
Testing Laboratory: Freedom Diagnostics
> Search Code: 21Pe2602230201
Analytical Verification
Identity Confirmation: Mass spectrometry confirms the molecular structure of KPV, GHK-Cu, Thymosin Beta-4 (TB-500), and BPC-157.
Chromatographic Analysis: HPLC chromatogram verifies peptide purity and separation profile.
Testing Method:
- High-Performance Liquid Chromatography (HPLC)
- Mass Spectrometry (LCMS/MS)
Laboratory:
- Freedom Diagnostics - USA
- Principal Chemist: Stephen Schmidt